Our research benefits from an external network of more than300academic and 100industry alliances focused on areas of mutual scientific interest.Collaborations can boost efficiency and accelerate progress by facilitating access to ideas， capabilities and talent not always available within our walls.By joining forces with external innovators to pursue shared scientific interests，we can increase the breadth and depth of the science covered。
建筑用过热器
We seek collaborations that：
- 支护桥下支护板
- 可访问的导航设备和导航设备
- Gain access to drug discovery programs and drug candidates that seek to address significant unmet medical need
- Explore science outside the current internal strategy that have the potential to set future biomedical directions
Through our open approach to drug discovery，we are focusing on new technologies to develop the next generation of therapeutics.We are teamed up with leading academic experts and biotechnology companies in fields such asoncology，immuno-oncology，ophthalmology，regenerative muciosy，nourney。
Collaborations help energize emerging fields of biomedicine and enable us to tackle longstanding research challenges.We are currently working with Olionis Biosciences to more rapidly identify and prioritize new targets at agenome-wide scale.By combining our expertise in drug discovery and delovelopment，inoth， we aim to seekout historically elusive targets and work to bring novel small molecule therapeutics to patients more quickly。
Together with the University of California， Berkeley we opened a center focused on the portion of the proteome that has been historically difficult to drug with small molecules.This collaboration organizes a diverse group of leading experts around a major challenge in drug discovery.Using emerging technologies to identify prointerbinding inteports s， our teams together with collaborators at Berkeley，are working to target hard to reach proteins that have long evaded drug hunters。
Learn more about our academic collaborations
